Reagila® used in paranoid schizophrenia – a case reportadmin2021-07-21T05:17:56+00:00
- Home
-
Over Reagila
-
Werkingsmechanisme
Werkingsmechanisme
-
Klinische data
Klinische data
- REAGILA in Patients with Acute Exacerbation of Schizophrenia
- REAGILA in The Long-Term Treatment of Schizophrenia
- REAGILA Controls Negative Symptoms in Schizophrenia
- Controlling Everyday Functioning with REAGILA®
- REAGILA’s Effects on Primary and Secondary Negative Symptoms: Pseudospecificity
- The Safety and Tolerability Profile of REAGILA
- The Management of Akathisia
- Cariprazine and Weight Gain
-
-
Reagila Voorschrijven
-
Educatie & events
-
Aan te vragen